Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 32 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

6%

2 trials in Phase 3/4

Results Transparency

22%

2 of 9 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

27Total
Not Applicable (20)
P 1 (2)
P 2 (3)
P 3 (2)

Trial Status

Recruiting14
Completed9
Not Yet Recruiting5
Enrolling By Invitation2
Withdrawn1
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (32)

Showing 20 of 20 trials
NCT07329673Recruiting

An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms

NCT06198023Not ApplicableRecruiting

Targeting Social Function in Anxiety and Eating Disorders

NCT07430800Not ApplicableRecruitingPrimary

Personalized AI-Driven Models in Cognitive Behavioral Therapy for Anxiety

NCT07391020Not ApplicableRecruitingPrimary

Text Message Safety Behavior Fading for Pathological Worry

NCT07541443Not ApplicableNot Yet RecruitingPrimary

Miles for Mental Health

NCT06937892Not ApplicableRecruitingPrimary

Transdiagnostic Metacognitive Therapy Compared to Disorder-Specific Cognitive-Behavioral Therapy for Anxiety Disorders

NCT06804525Recruiting

LHC-CIDI-5 in Hong Kong

NCT07123467Phase 3RecruitingPrimary

Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder

NCT07228143Not ApplicableRecruitingPrimary

Stepped Care Treatment for Anxiety Resilience

NCT07429578Not ApplicableRecruitingPrimary

Transcranial Alternating Current Stimulation for Generalized Anxiety Disorder and Insomnia: An Open-Label Pilot Study

NCT07129408Completed

Epidemiological Study on the Prevalence of Mental Disorders in Slovakia

NCT06846320Phase 2RecruitingPrimary

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

NCT07225192Not ApplicableNot Yet RecruitingPrimary

Therapy and Tech Study

NCT07201844Not ApplicableRecruitingPrimary

The Effect of Patient Preference for Treatment Model in Internet Delivered Cognitive Behavior Therapy for Generalized Anxiety Disorder

NCT07177365Not ApplicableNot Yet RecruitingPrimary

Internet-Based Cognitive Behavioral Therapy With Treatment as Usual for Generalized Anxiety Disorder and Major Depressive Disorder in Taiwan (ICBT-TW)

NCT07024758Not ApplicableRecruiting

Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolescents With Anxiety and OCD

NCT06971692Not ApplicableNot Yet Recruiting

Metacognitive Therapy vs Unified Protocol for Patients With Comorbid Anxiety Disorders

NCT06969170Phase 2RecruitingPrimary

Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder

NCT06698471Not ApplicableActive Not Recruiting

Relief From Stress Via Social Protection in Senegal

NCT06931236Not ApplicableEnrolling By InvitationPrimary

Clinical Efficacy and Mechanism of rTMS Based on dlPFC in the Intervention of Generalized Anxiety Disorder With Insomnia

Scroll to load more

Research Network

Activity Timeline